Follow
Kusum Rathore
Kusum Rathore
Vice President at UTRF/ Licensing and Intellectual Property Management
Verified email at utk.edu - Homepage
Title
Cited by
Cited by
Year
Animal models and therapeutic molecular targets of cancer: utility and limitations
M Cekanova, K Rathore
Drug design, development and therapy, 1911-1922, 2014
3152014
Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis
K Rathore, S Choudhary, A Odoi, HCR Wang
Carcinogenesis 33 (1), 174-183, 2012
672012
Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone and benzo [a] pyrene
X Song, N Siriwardhana, K Rathore, D Lin, HCR Wang
Molecular Carcinogenesis: Published in cooperation with the University of …, 2010
552010
Molecular Imaging of Cyclooxygenase-2 in Canine Transitional Cell Carcinomas In Vitro and In Vivo
M Cekanova, MJ Uddin, JW Bartges, A Callens, AM Legendre, K Rathore, ...
Cancer Prevention Research 6 (5), 466-476, 2013
462013
Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro
K Rathore, M Alexander, M Cekanova
Translational Research 164 (2), 158-168, 2014
432014
Green tea catechin extract in intervention of chronic breast cell carcinogenesis induced by environmental carcinogens
K Rathore, HCR Wang
Molecular carcinogenesis 51 (3), 280-289, 2012
422012
Inhibition of the PI3K/AKT pathway sensitizes oral squamous cell carcinoma cells to anthracycline‐based chemotherapy in vitro
D Smolensky, K Rathore, J Bourn, M Cekanova
Journal of cellular biochemistry 118 (9), 2615-2624, 2017
412017
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer
D Smolensky, K Rathore, M Cekanova
Drug Design, Development and Therapy, 3305-3322, 2016
382016
Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells
S Choudhary, K Rathore, HCR Wang
Journal of cancer research and clinical oncology 137, 471-480, 2011
312011
Aligned nanofiber material supports cell growth and increases osteogenesis in canine adipose‐derived mesenchymal stem cells in vitro
S Pandey, K Rathore, J Johnson, M Cekanova
Journal of Biomedical Materials Research Part A 106 (7), 1780-1788, 2018
252018
Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines
K Rathore, M Cekanova
BMC cancer 14, 1-10, 2014
242014
Evaluation of the role of the cyclooxygenase signaling pathway during inflammation in skin and muscle tissues of ball pythons (Python regius)
RA Sadler, JP Schumacher, K Rathore, KM Newkirk, G Cole, R Seibert, ...
American journal of veterinary research 77 (5), 487-494, 2016
232016
Mesenchymal and stem-like cell properties targeted in suppression of chronically-induced breast cell carcinogenesis
K Rathore, HCR Wang
Cancer letters 333 (1), 113-123, 2013
222013
Spo0B of Bacillus anthracis–a protein with pleiotropic functions
AR Mattoo, M Saif Zaman, GP Dubey, A Arora, A Narayan, N Jailkhani, ...
FEBS Journal 275 (4), 739-752, 2008
182008
Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro
D Smolensky, K Rathore, M Cekanova
BMC cancer 15, 1-11, 2015
172015
A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro
K Rathore, M Cekanova
Drug design, development and therapy, 5323-5335, 2015
172015
FK228 and oncogenic H-Ras synergistically induce Mek1/2 and Nox-1 to generate reactive oxygen species for differential cell death
S Choudhary, K Rathore, HCR Wang
Anti-cancer drugs 21 (9), 831-840, 2010
172010
Effects of environmental carcinogen benzo (a) pyrene on canine adipose-derived mesenchymal stem cells
MC Kusum Rathore
Research in Veterinary Science 103, 34-43, 2015
132015
Detection of carcinogen-induced bladder cancer by fluorocoxib A
J Bourn, K Rathore, R Donnell, W White, MJ Uddin, L Marnett, ...
BMC cancer 19, 1-13, 2019
62019
Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther. 2014; 8: 1911–21
M Cekanova, K Rathore
6
The system can't perform the operation now. Try again later.
Articles 1–20